ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NMTR 9 Meters Biopharma Inc

0.0722
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
9 Meters Biopharma Inc NASDAQ:NMTR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0722 0.12 0.124 0 01:00:00

Additional Proxy Soliciting Materials (definitive) (defa14a)

29/09/2022 9:17pm

Edgar (US Regulatory)



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934

Filed by the Registrant  ☒Filed by a Party other than the Registrant  ☐

Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant Rule §240.14a-12
9 Meters Biopharma, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 4a-6(i)(1) and 0-11



nmtrlogo.jpg                    8480 Honeycutt Road, Suite 120
Raleigh, NC 27615

URGENT – TIME IS SHORT
PLEASE VOTE YOUR PROXY TODAY

September 29, 2022
Dear Stockholder,

According to our latest records, we have not received your voting instructions for the Special Meeting of Stockholders of 9 Meters Biopharma, Inc., which on September 23rd had to be adjourned due to lack of quorum, and which is scheduled to resume on October 21, 2022. If you have not voted, we urge you to do so as promptly as possible. Your vote is very important, no matter how many shares you hold.

For the reasons set forth in the proxy statement, dated August 2, 2022, the Board of Directors unanimously recommends that you vote “FOR” the Nasdaq Proposal. Please vote via the internet or phone as soon as possible or alternatively, please sign, date, and return the enclosed proxy card.

On behalf of your Board of Directors, thank you for your cooperation and continued support.

Sincerely,

/s/ John Temperato
John Temperato
President and Chief Executive Officer

THREE EASY WAYS TO VOTE
waystovote.jpg
D.F. King & Co, Inc.
Call Toll-Free: (866) 829-1035
Email: 9meters@dfking.com    

1 Year 9 Meters Biopharma Chart

1 Year 9 Meters Biopharma Chart

1 Month 9 Meters Biopharma Chart

1 Month 9 Meters Biopharma Chart

Your Recent History

Delayed Upgrade Clock